Scientists have leveraged fundamental features of chemical building blocks to transform chemical reaction analysis from minutes to milliseconds. The development of molecules to study and treat disease ...
Argobio Studio, the launch platform for Europe's best innovative science, today announced the successful seed financing of Enodia Therapeutics, a ...
Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...
For Daniil Boiko and Andrei Tyrin, the idea for Onepot AI came from the same frustration. “The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch.
Synfini, Inc., provider of the industry's most advanced Agile AI Foundry for drug discovery, today announced the launch of Fast Pass I, an open, rapid cloud workflow system which provides qualified ...
Deerfield Management, Khosla Ventures, and Sofinnova Partners co-lead Series A fundraise for Excelsior Sciences to accelerate drug discovery and clinical development while supporting pharma reshoring.
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Howard Hughes Medical Institute scientists have simplified the chemical synthesis of small molecules, eliminating a major bottleneck that limits the exploration of a class of compounds offering ...
From structure confirmation to methodology improvements, making complex natural products has driven innovation in organic ...
Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback